Peptide-based Cancer Therapeutics Market Size, Forecast to 2035
The global peptide-based cancer therapeutics market refers to the pharmaceutical industry focused on using therapeutic peptides to treat cancer. There is an upsurge in the development of therapeutic peptides for a wide range of diseases, especially cancer. They are preferably used over antibiotics, radiation therapy, and chemotherapy owing to their flexibility, easy modification, low immunogenicity, and inexpensive production cost. Innovation and market expansion are anticipated as a result of major players\' growing R&D expenditures and expanding partnerships.